Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
64 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02864888 | Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem Glioma(DBSG) | not yet recruiting | Phase 3 | 30 | Burzynski Research InstituteOTHER | 0 | Sep 19, 2025 | clinicaltrials |
| NCT02742883 | A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG) | suspended | Phase 2 | 1 | Burzynski Research InstituteOTHER | 1 | Sep 16, 2025 |
| NCT02887040 | Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma(DIPG) | not yet recruiting | Phase 3 | 92 | Burzynski Research InstituteOTHER | 0 | Sep 16, 2025 | clinicaltrials |
| NCT00003458 | Antineoplaston Therapy in Treating Children With Brain Tumors | completed | Phase 2 | 34 | Burzynski Research InstituteOTHER | 1 | Mar 7, 2022 | clinicaltrials |
| NCT00003479 | Antineoplaston Therapy in Treating Patients With Ependymoma | terminated | Phase 2 | 9 | Burzynski Research InstituteOTHER | 1 | Feb 23, 2022 | clinicaltrials |
| NCT00003511 | Antineoplaston Therapy in Treating Patients With Multiple Myeloma | terminated | Phase 2 | 5 | Burzynski Research InstituteOTHER | 1 | Jun 9, 2021 | clinicaltrials |
| NCT00003487 | Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus | terminated | Phase 2 | 8 | Burzynski Research InstituteOTHER | 1 | May 14, 2021 | clinicaltrials |
| NCT00003508 | Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma | terminated | Phase 2 | 8 | Burzynski Research InstituteOTHER | 1 | Apr 27, 2021 | clinicaltrials |
| NCT00003498 | Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma | terminated | Phase 2 | 5 | Burzynski Research InstituteOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT00003531 | Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer | terminated | Phase 2 | 15 | Burzynski Research InstituteOTHER | 1 | Jan 7, 2021 | clinicaltrials |
| NCT00003509 | Antineoplaston Therapy in Treating Patients With Stage IV Melanoma | terminated | Phase 2 | 13 | Burzynski Research InstituteOTHER | 1 | Dec 19, 2020 | clinicaltrials |
| NCT00003526 | Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin | terminated | Phase 2 | 8 | Burzynski Research InstituteOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT00003492 | Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer | terminated | Phase 2 | 9 | Burzynski Research InstituteOTHER | 1 | Dec 16, 2020 | clinicaltrials |
| NCT00003499 | Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma | completed | Phase 2 | 31 | Burzynski Research InstituteOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT00003453 | Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer | terminated | Phase 2 | 6 | Burzynski Research InstituteOTHER | 1 | May 9, 2018 | clinicaltrials |
| NCT00003456 | Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme | completed | Phase 2 | 40 | Burzynski Research InstituteOTHER | 1 | Mar 22, 2018 | clinicaltrials |
| NCT00003471 | Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma | terminated | Phase 2 | 7 | Burzynski Research InstituteOTHER | 1 | Mar 22, 2018 | clinicaltrials |
| NCT00003474 | Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme | completed | Phase 2 | 40 | Burzynski Research InstituteOTHER | 1 | Mar 22, 2018 | clinicaltrials |
| NCT00003472 | Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma | terminated | Phase 2 | 13 | Burzynski Research InstituteOTHER | 1 | Mar 21, 2018 | clinicaltrials |
| NCT00003535 | Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma | terminated | Phase 2 | 9 | Burzynski Research InstituteOTHER | 1 | Mar 21, 2018 | clinicaltrials |
| NCT00003459 | Antineoplaston Therapy in Treating Patients With Brain Stem Glioma | completed | Phase 2 | 40 | Burzynski Research InstituteOTHER | 1 | Mar 14, 2018 | clinicaltrials |
| NCT00003497 | Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer | terminated | Phase 2 | 9 | Burzynski Research InstituteOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT00003500 | Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma | terminated | Phase 2 | 12 | Burzynski Research InstituteOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT00003501 | Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma | terminated | Phase 2 | 2 | Burzynski Research InstituteOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT00003512 | Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia | withdrawn | Phase 2 | 0 | Burzynski Research InstituteOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT00003516 | Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer | terminated | Phase 2 | 16 | Burzynski Research InstituteOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT00003494 | Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer | terminated | Phase 2 | 4 | Burzynski Research InstituteOTHER | 1 | Jan 31, 2018 | clinicaltrials |
| NCT00003534 | Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer | withdrawn | Phase 2 | 0 | Burzynski Research InstituteOTHER | 1 | Jan 31, 2018 | clinicaltrials |
| NCT00003473 | Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas | completed | Phase 2 | 20 | Burzynski Research InstituteOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT00003532 | Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer | terminated | Phase 2 | 7 | Burzynski Research InstituteOTHER | 1 | Dec 12, 2017 | clinicaltrials |
| NCT00003533 | Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer | terminated | Phase 2 | 12 | Burzynski Research InstituteOTHER | 1 | Dec 12, 2017 | clinicaltrials |
| NCT00003489 | Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer | terminated | Phase 2 | 7 | Burzynski Research InstituteOTHER | 1 | Nov 21, 2017 | clinicaltrials |
| NCT00003530 | Antineoplaston Therapy in Treating Patients With Primary Liver Cancer | terminated | Phase 2 | 3 | Burzynski Research InstituteOTHER | 1 | Nov 21, 2017 | clinicaltrials |
| NCT00003491 | Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer | terminated | Phase 2 | 17 | Burzynski Research InstituteOTHER | 1 | Sep 29, 2017 | clinicaltrials |
| NCT00003515 | Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors | terminated | Phase 2 | 1 | Burzynski Research InstituteOTHER | 1 | Sep 29, 2017 | clinicaltrials |
| NCT00003520 | Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer | terminated | Phase 2 | 15 | Burzynski Research InstituteOTHER | 1 | Sep 29, 2017 | clinicaltrials |
| NCT00003521 | Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma | terminated | Phase 2 | 14 | Burzynski Research InstituteOTHER | 1 | Sep 29, 2017 | clinicaltrials |
| NCT00003522 | Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine | terminated | Phase 2 | 1 | Burzynski Research InstituteOTHER | 1 | Sep 29, 2017 | clinicaltrials |
| NCT00003524 | Antineoplaston Therapy in Treating Patients With Stomach Cancer | terminated | Phase 2 | 1 | Burzynski Research InstituteOTHER | 1 | Sep 29, 2017 | clinicaltrials |
| NCT00003525 | Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva | terminated | Phase 2 | 8 | Burzynski Research InstituteOTHER | 1 | Sep 29, 2017 | clinicaltrials |
| NCT00003452 | Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder | terminated | Phase 2 | 4 | Burzynski Research InstituteOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT00003454 | Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer | terminated | Phase 2 | 19 | Burzynski Research InstituteOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT00003485 | Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer | terminated | Phase 2 | 15 | Burzynski Research InstituteOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT00003495 | Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer | terminated | Phase 2 | 7 | Burzynski Research InstituteOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT00003496 | Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer | terminated | Phase 2 | 4 | Burzynski Research InstituteOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT00003513 | Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma | terminated | Phase 2 | 3 | Burzynski Research InstituteOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT00003460 | Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors(PNET) | completed | Phase 2 | 13 | Burzynski Research InstituteOTHER | 1 | Aug 24, 2017 | clinicaltrials |
| NCT00003469 | Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System | terminated | Phase 2 | 4 | Burzynski Research InstituteOTHER | 1 | Aug 24, 2017 | clinicaltrials |
| NCT00003470 | Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma(AA) | completed | Phase 2 | 27 | Burzynski Research InstituteOTHER | 1 | Aug 24, 2017 | clinicaltrials |
| NCT00003475 | Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors | completed | Phase 2 | 40 | Burzynski Research InstituteOTHER | 1 | Aug 24, 2017 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials